Kurdistan Board for Medical Speciality Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04201951
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kurdistan Board for Medical Speciality

Active Ingredients

Drugs in Other Trials (1)

tranexamic acid (cyklokapron) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1